Artificial Intelligence

A new intraoperative MRI gives surgeons real-time vision, promising more precise and safer glioma removal as it moves toward the competitive U.S. market.

Morningstar's investment chief joins a health AI firm, signaling a new era where financial modeling principles could unlock preventative wellness for millions.

The Boston-based startup's Bronze Stevie Award for AI Company of the Year validates its patented approach to automating tedious real estate invoice coding.

A new patent for a compact quantum atomic clock could revolutionize navigation and defense, placing Quantum X Labs in a high-stakes race for GPS independence.

With 14 years of losses and soaring claims, the commercial auto market is in peril. A new report reveals how AI and data are fighting back.

A new report reveals Canada's Intelligence Commissioner is pushing back on spy agencies, protecting rights and democratic institutions like never before.

The new Gibco CTS DynaXS bioreactor aims to unlock scalable production, making life-saving cell therapies more accessible and affordable for patients.

The Canadian Museum of History's new VR saga lets you walk with Napoleon. Is this the future of museums or a high-tech gamble? We investigate.

Scott Drennan takes the helm at Otto Aerospace, tasked with turning the visionary, ultra-efficient Phantom 3500 jet from concept to certified reality.

A new report shows striking optimism among U.S. small businesses, but a deeper look reveals critical challenges in customer demand and a stark disconnect with government policy.

With a fresh $26M, Enzo Health's AI platform aims to tackle clinician burnout and operational chaos in the booming but strained post-acute care market.

New AI tools create mortgage presentations in seconds, promising to level the playing field for loan officers while raising questions of trust and regulation.

A new $100M fund is ditching traditional VC models, offering infrastructure capital to lure deep tech firms and reshape New Mexico’s economic landscape.

A German biotech's novel in vivo CAR T platform uses DNA for durable tumor control, aiming to make advanced cancer therapy an off-the-shelf medicine.

The HLAA 2026 convention showcases AI breakthroughs, policy debates, and the power of community for 50 million Americans with hearing loss.

A new testing platform from Armatus Bio aims to break a major bottleneck in gene therapy, promising faster paths to cures for rare neuromuscular diseases.

Standard skin checks often miss deadly melanomas. An Arizona dermatologist sounds the alarm on a critical detection gap and a tool that could save lives.

The clinical-stage biotech adds seasoned veterans from Eli Lilly and Iovance to accelerate its promising DNA Damage Response pipeline toward commercialization.

A new anechoic chamber in Syracuse allows Hidden Level to fast-track advanced RF systems, bolstering U.S. defenses against growing unmanned aerial threats.

NuCube Energy brings advanced microreactors to Arizona, aiming to solve the state's power crisis fueled by booming data center and chip manufacturing demands.